Asserewou Etekpo Selected Research

6'-N-methylsisomicin (G 52)

9/2020

The Synergistic Effect of an ATP-Competitive Inhibitor of mTOR and Metformin on Pancreatic Tumor Growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Asserewou Etekpo Research Topics

Disease

4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 11/2014
2	Neoplasms (Cancer) 09/2020 - 01/2018
1	Cysts 01/2018
1	Pancreatic Cyst 01/2018

Drug/Important Bio-Agent (IBA)

2	GTP Phosphohydrolases (GTPases)IBA 01/2020 - 11/2014
1	6'-N-methylsisomicin (G 52)IBA 09/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 09/2020
1	Adenosine Triphosphate (ATP)IBA 09/2020
1	Metformin (Glucophage)FDA LinkGeneric 09/2020
1	Mechanistic Target of Rapamycin Complex 2IBA 09/2020
1	torinIBA 09/2020
1	Mucin-4IBA 01/2018
1	EpitopesIBA 01/2018
1	MucinsIBA 01/2018
1	ParaffinIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2017
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2017

Therapy/Procedure

1	Therapeutics 09/2020
1	Radiotherapy 11/2014